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In 1965 a preliminary study revealed the protective effect of oral chloram-
phenicol in adult male Wistar rats against hepatic carcinogenesis and cir-
rhosis induced by feeding 0.05%o N-2-fluorenyldiacetamide in a semisyn-
thetic diet of Morris.! The chloramphenicol was fed at the level of 2 percent
in the diet as the maximal tolerated dose according to the recommendation
of Dr. A. C. Bratton, Jr., Director of Pharmacological Research at Parke,
Davis, and Company who donated the chloramphenicol for both the pre-
liminary and the present study.
Once the preliminary study had demonstrated the effectiveness of a maxi-
mal dose of chloramphenicol, it was decided to determine whether such a
large dose was necessary and at what level of dosage significant inhibition
could be obtained, using the same model that had been employed in this
laboratory for many years in studies of the role of sex and various hormones
in hepatic carcinogenesis.' Also, to what extent was the carcinogen and/or
its metabolites bound to protein in the liver cells?
PROCEDURE
EXPERIMENT I
One hundred male F1 hybrid rats, each weighing between 150 and 175 grams, off-
spring of inbred AXC males and commercial Sprague-Dawley females, were selected
and-divided into four groups of 25 rats each. The animals were fed a semi-synthetic
diet of Morris (Table 1) to which was added 0.025 percent N-2-fiuorenyldiacetamide¶
and varying concentrations (0-control, 0.1%, 0.5% and 2%) of chloramphenicol.
The diet was fed by modified pair-feeding with 5 rats per cage. The amount of diet
offered in each cage was controlled by the amount eaten per day-by the control group
given carcinogen but no chioramphenicol in the diet. This control group ate the least
and all the other groups consumed all of the limited diet offered. The animals had free
access to water at all times. Each animal was-numbered and weighed weekly through-
out the experiment.
The carcinogenic diet was fed for three periods of four weeks each with one week
between each of the four-week periods when the rats were fed the same semi-synthetic
* Experimental Pathology Trainee supported by NIH Training Grant GM00431.
** Professor of Pathology.
t Research Assistant.
t Project supported in part by a grant from the American Cancer Society.
¶ Aldrich Chemical Company, 2369 North 29th Street, Milwaukee, Wisconsin.
Received for publication 28 April 1970.YALE JOURNAL OF BIOLOGY AND MEDICINE Vol.43,February,April,1971
TABLE 1. MoaRIs DiET
Commercial casein 300 gm.
Skim-milk powder 2,275 "
Ground, hard spring
wheat 6,152
Brewer's yeast 200
Desiccated whole-liver
powder (Wilson) 200
Sodium chloride 140
Ascorbic acid 10
Ferric citrate 13
Cod-liver oil 100
Corn'oil 610
diet and dose of chloramphenicol but no carcinogen. Following the twelfth week of
carcinogen the animals received two weeks of semi-synthetic diet containing the ap-
propriate dose of chloramphenicol but no carcinogen and then all of the rats were
placed on Purina Laboratory Chow pellets ad libidum.
The animals were kept alive for up to 68 weeks, after which they were killed and
examined. All rats were autopsied and tissues were fixed in 10 percent formalin. Blocks
of liver and lungs from each animal were embedded in paraffin, sectioned and stained
with hematoxylin and eosin. In those animals with lesions in other organs, microscopic
sections were similarly prepared for examination. Previous studies' had shown that a
minimum of 25 weeks was necessary from the time the feeding of carcinogen was begun
for the first hepatocellular carcinoma to develop. Consequently, four animals that died
prior to 25 weeks were dropped from the experiment and are not included in the re-
sults shown in Table 2. All of the animals tabulated lived for 45 weeks or more after
the start of the experiment.
EXPERIMENT II
In an attempt to determine'to what extent N-2-fluorenyldiacetamide and/or'. its,, meta-
bolic products were boun'd'into the protein of the liver cells, a separate short-term ex-
periment was also performed. Forty-nine m'a,le-Wistar rats and e,ight fem,ales, weighing
200 to 250 grams each, were divided into four groups. Twenty males, were fed the basic
semi-synthetic diet without carcinogen or chloramphenicol. Three were killed each week
for the first four weeks and two each 'succeeding week through 8 weeks ; they served
as baseline controls. Seventeen male rats were fed the diet containing ,carcinogen and
were sacrificed at weekly intervals, generally two to three rats at a time 'for'four weelks
and three more at eight weeks.' The eight female rats were treated similarly, with
analysis of the liver protein from two animals'per period. The reinaining twelve male
rats were fed 2 percent chloramphenicol in the carcinogen-containing diet and sacrificed
periodically, generally in pairs up to four and a half weeks. Six rats were killed at 8
weeks following the start of the experiment.' The amiiount of protein-bound carcinogen
or its metabolic products in the, liver was determined by the method dtailed. below.
At the time of sacrifice of each animal the liver was removed, protein extracted and
ultraviolet absorption at 554 m, was measured as an index of fluorenyl content accord-
ing to the following procedure: The rats were anesthetized with ether. The abdomen of
the rat was opened and the liver perfused with 35 ml;. of cold. 0.9% sodium chloride by
injecting the portal vein after cutting the hepatic at,r,tgy and inferior vena ;,cava. The
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liver was then removed, rinsed in cold 0.9% saline and blotted with absorbent paper,
weighed, and 2 gm. aliquots were minced finely with scissors. The minced liver was
placed in ten times its volume of saline and ground in a Duall homogenizer. The liver
proteins were precipitated from the homogenized liver suspension by the addition of an
equal volume of cold 10% trichloracetic acid (TCA). The liver proteins were sedi-
mented by centrifuging in an International refrigerated centrifuge at 2,500 rpm for 15
minutes. The supernatent fluid was discarded and the precipitated proteins were washed
again with 10% cold TCA. The TCA-precipitated liver proteins were then washed with
cold 95% ethanol-chloroform (3 to 1 by volume), ethanol-diethyl ether (3 to 1 by vol-
ume) and diethyl ether. The granular, tissue-protein residue was placed in a preweighed
evaporating dish, dried in a vacuum dessicator over calcium sulfate for 24 hours and
weighed. Approximately 0.25 grams of powdered liver protein was obtained from each
2 gram aliquot of rat liver by this extraction procedure. Aliquots from this powdered
tissue-protein extract were used for determination of fluorenyl content.
Fifty milligrams of dried rat liver protein from rats which had been fed the Morris
diet containing N-2-fluorenyldiacetamide were placed in screw-capped test tubes con-
taining 5 ml. of a mixture of two volumes of 95% ethanol and three volumes of con-
centrated hydrochloric acid. The acid-alcohol mixture containing the rat liver protein
was placed in a 70°C. water bath and allowed to incubate for 1X2 hours. A reddish-
purple color developed in the solvent from the rat liver protein samples that were taken
from the rats which had been fed the semi-synthetic diet that contained N-2-fluorenyldi-
acetamide. The color developed slowly and reached a peak intensity after approximately
45 minutes of incubation. A spectral analysis was made using a Beckman DU spec-
trophotometer and the peak absorbancy of the liberated color occurred at 554 milli-
microns, which corresponds to the color and absorption of known fluorenyl compounds
studied in this laboratory.
RESULTS
EXPERIMENT I
All of the groups of animals lost weight initially but in 2 to 3 weeks they
had regained their loss. Thereafter, there was a progressive gain in weight
which began to level off at about 40 weeks and after about 55 weeks there
was a gradual loss of weight (Figure 1). The growth curves are quite simi-
lar among the four groups except terminally when the control group, which
had the highest incidence of tumors, began to lose weight quite rapidly and
averaged 48 grams per animal less than the most protected group on 2 per-
cent chloramphenicol, 38 grams less than the group on 0.5 percent chloram-
phenicol and 22 grams less than the group on 0.1 percent chloramphenicol
(Table 2).
The main findings at autopsy of the four groups of rats are shown in
Table 2.
In the control group receiving carcinogen but no chloramphenicol, 24 ani-
mals survived from 52 to 68 weeks. Of these, 18 lived 68 weeks, 16 de-
veloped hepatocellular carcinomas, and 1, hyperplastic nodules. In the six
animals that expired prior to 68 weeks, three had tumors and two, hyper-
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AVERAGE
BODY
WEIGHT
(grams)
Corcinogen
Carcinogen 0.1 % Chloromphenicol
---- Carcinogen 0.5/. Chloromphenicol
. sttelol11159 Carcinogen 2.0% Chloramphenicol
10 I5 20 25 30 35 40 45 50 55
WEEKS AFTER START OF CARCINOGEN
FIG. 1.
plastic nodules. In this group, three animals developed pulmonary metastases
from their hepatic carcinomas. All showed cystic changes in the liver, vary-
ing from minimal (10 animals) to moderate or extensively involved (14
animals). Five animals had neoplasms other than hepatocellular carcinomas
in this group. They consisted of three bronchoalveolar cell tumors of the
lung, one squamous cell carcinoma of the ceruminous gland of the ear and
one bile duct adenoma. The liver weights varied from 21 to 106 grams and
averaged 50.9 grams. Cirrhosis was not present in this or any of the subse-
TABLE 2. RATS FED 0.025% N-2-FLUORENYLDIACETAMIDE FOR 12 OF 14 WEEKS
Chtoram- Final Avg.
phenicol fed avg.wt. liver Hepatocellular Other
16 weeks Animals difference wt. carcinomas Cysts tumors
percent number gis. gm.. number % number number
0 24 - 50.9 19 79 24 5
0.1 23 +22 48.6 15 65 22 2
0.5 25 +38 35.3 15 60 19 1
2.0 24 +48 22.1 4 17 4 8
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quent groups, but bile duct cysts were present in the liver of all of the ani-
mals in this group.
Twenty-three animals survived from 45 to 68 weeks in the group that re-
ceived carcinogen plus 2%o chloramphenicol. Sixteen lived 68 weeks and 12
of these had normal livers, two had small hyperplastic nodules and two de-
veloped hepatocellular carcinomas. Of the eight animals that expired prior
to 68 weeks, two had hepatocellular carcinomas and one of these had pul-
monary metastases. Minimal to moderate focal cystic changes were evident
in the four animals with liver tumors. Eight neoplasms other than those in
the liver were present: Four of these were squamous cell carcinomas from
the ear, one was a large subcutaneous fibroma, two were transitional cell
carcinomas from the urinary bladder, and one was a collision tumor con-
sisting of both parenchymal adenocarcinoma of the kidney and transitional
cell carcinoma of the renal pelvis. The livers varied from ten to thirty-
seven grams in this group and averaged 22.1 grams.
In the group receiving 0.1%o chloramphenicol in the carcinogen-containing
diet, 23 animals lived from 50-68 weeks. Thirteen of 20 rats that were
sacrificed at 68 weeks and two of three animals expiring prior to 68 weeks
had hepatocellular carcinomas. Two had developed pulmonary metastases
from their tumors. In two animals, hyperplastic hepatic nodules were pres-
ent. Hepatic cystic changes were present in all the animals with liver tumors
and in seven without liver tumors. In seven the cystic changes were con-
sidered minimal, and in 15, moderate to marked. Two additional tumors,
one bronchoalveolar cell tumor of the lung and one subcutaneous fibroma,
were present. Liver weights ranged from 30 to 105 grams, and averaged
48.6 grams.
In the remaining group which received 0.5%b chloramphenicol with the
carcinogen in the diet, 25 animals survived 46 to 68 weeks. Eleven of 18
sacrificed at 68 weeks had hepatocellular carcinomas, while four of seven
that had expired previously had such tumors. Two animals had pulmonary
metastases. Nine animals showed minimal cystic changes in the livers, and
in ten the cystic changes were considered moderate to marked. No hepatic
cystic changes were present in three of the rats with hepatocellular carci-
nomas. Only one additional tumor, a papillary transitional cell carcinoma of
the urinary bladder was present in this group. Hepatic weights varied from
16 to 76 grams and averaged 35.3 grams.
The protective effect of chloramphenicol is represented graphically in
Figure 2.
Statistical analysis of these results using a modified X2 teste reveals highly
significant influence of dosage on chloramphenicol inhibition with a p value
of <<0.001.
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EXPERIMENT II
Plots of the absorption of the acidified liver protein extracted from the
four groups of rats in Experiment II are shown in Figure 3..
The decrease in-content of 554 m,L absorbing fluorenyl compound.in the
liver of the relatively immune female rats, compared to male rats, is clearly
evident. After one week, a statistical analysis applying the standard "t" test
to these two groups revealed a significance with a p. << 0.001.
Male rats protected by the addition of 2%o chloramphenicol to.their diet
showed some delay in obvious inhibition of binding but clearly diverged
after three weeks from the male animals. fed carcinogen only. The signifi-
cance of. decreased binding in the chloramphenicol group similarly has a p
value of << 0.001. In a separate experiment not included here, in which
rats were fed a diet containing. double .the dose of carcinogen (0.05%o) as
was used in the long-term experiment reported previously, entirely com-
parable inhibition occurred in the chloramphenicol-treated rats.
DISCUSSION
Previous studies had shown the procarcinogenic action of androgenic and
anabolic hormones in this model.' It was known from the work of the Mil-
lers" and otherse' that the carcinogen was bound to protein in the liver.
Although these hormonal effects might increase the net metabolic quantity
of active proximate carcinogen in the liver, it seemed more likely that the
effects of the anabolic hormones was through increased protein synthesis in
the liver which bound more carcinogen as an integral component when pro-
tein intake was partially restricted.
The role of the anabolic hormones as described by Kochakian° was con-
sidered to be the induction of more protein synthetic machinery in the liver
302h OSTER, FIRMINGER, MORRISON
cells, such as aspartic-glutamic transaminase, alanine-glutamic transaminase
and d-amino acid oxidase. Reuber10 showed the simultaneous need for thyroid
hormone to maintain or increase the production rate by the synthetic ma-
chinery and presumably, thereby, the binding of carcinogen in the liver cells.
If protein synthesis is an integral part of the mechanism ofcarcinogenesis,
PROTEIN-BOUND CARCINOGEN
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FIG. 3. Each point represents the determination from an individual animal. The zero
time represents the average optical density of the extracts from 20 male rats fed the
basic diet and killed periodically up to eight weeks after the start of the experiment.
The range at zero time represents the 95% confidence limit for basic diet determina-
tions.
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perhaps an agent which is known to block protein synthesis in bacteria` in
rabbit reticulocytes,p reproduction of normal human marrow cells and leu-
kemic cells,1' and synthesis of antibody in tissue cultures and yet which is
not overly toxic for chronic experiments in rats might be anticarcinogenic.
Preliminary experiments did show striking protection not only against
hepatic carcinomas but also against cirrhosis.'
In the present experiments, cirrhosis of the liver was not seen at the time
of autopsy. Previous studiese using serial biopsies revealed that cirrhosis is
reversible on the 0.025% dosage of carcinogen and only the cysts do not
disappear. In the present experiment, the number and severity of the cystic
changes in the liver was inversely proportional to the dosage of chloram-
phenicol. It had been found previously that a higher dose of carcinogen in-
creases the degree and extent of cirrhosis more than it does the number of
tumors and the extent of involvement in the liver. This fact, together with
the shorter duration of the previous preliminary experiment, would seem
to account for the presence of cirrhosis in the unprotected controls in that
study.
The protective effect of chloramphenicol against the induction of hepato-
cellular carcinoma was confirmed by the present experiment and appears
clearly dose related, but the mechanism is still unknown. The preliminary
study of fluorenyl content of extracted liver protein does indicate decreased
binding after three weeks when chloramphenicol is fed with the carcinogen.
If binding in the liver is important in carcinogenesis and its binding is mere-
ly prevented by chloramphenicol, then the carcinogen should be released
and excreted in the urine. This seems to be borne out by the increased num-
ber of tumors outside the liver in the protected animals (8/24) on 2 percent
chloramphenicol compared to the threefold smaller number (8/72) in the
combined unprotected group and the two less-protected groups. These dif-
ferences are even more striking when one considers the increase only of the
ear duct and urinary tract tumors, usual products of the somewhat more
powerful but less specific N-2-fluorenylacetamide.& This is further substanti-
ated by Weisburger and his associatesu who showed that the amount of the
more carcinogenic N-hydroxy-N-2-fluorenylacetamide in the urine was in-
creased in rats fed N-2-fluorenyldiacetamide and concurrent chloram-
phenicol. These findings exclude a block in formation of the proximate
carcinogen or increased detoxication through inductive effects as the mecha-
nism of protective action of chloramphenicol.
The slower rise of bound compound in chloramphenicol-fed animals (Fig-
ure 3) may reflect a short temporary inhibition of protein synthesis. The
delayed fall of bound fluorenyl compound could suggest some inductive ac-
tion may have to occur before the chloramphenicol is effective.
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Weisburger and his associatese' showed no reduction of incorporation of
C1 labelled leucine into the protein pool of the liver in rats given chloram-
phenicol. Although this does not exclude possible inhibited production of a
specific protein it would seem to point strongly to competition between
chloramphenicol and the carcinogen as the mode of action of chloram-
phenicol. Of course the site of the competition, whether for enzyme, energy
mechanics, t-RNA or direct binding sites in protein or nucleic acids, is a
matter for further study.
SUMMARY
N-2-fluorenyldiacetamide-induced hepatic carcinogenesis in rats is effec-
tively inhibited by feeding 2% chloramphenicol in the diet and is shown to
be a dose-related phenomenon. Chloramphenicol effectively reduces binding
of the carcinogen in the liver but does not prevent its metabolic formation
or increase its detoxication. Instead it results in an increase in the types of
tumors induced by the carcinogen in sites outside the liver. The findings
suggest a competition between the carcinogen and chloramphenicol but the
binding sites and the mechanism of their action requires further study.
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